Expiring federal contract · order under a contract vehicle
36C24126N0170 — Abbott Rapid Dx North America LLC
Department of Veterans Affairs
- Contract / PIID
- 36C24126N0170
- Incumbent
- Abbott Rapid Dx North America LLC
- Incumbent UEI
- P782RNU1NNK3
- Current end date
- December 31, 2026
- Potential total value
- $123,000
- Obligated
- $123,000
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Set-aside
- Not stated
- Start date
- January 1, 2026
- Place of performance
- FL
- Award type
- BPA CALL
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
BINAXNOW TESTING SUPPLIES
Likely rebid window (estimate)
- Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
- RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)
In the final months before the current end date.
This is an order under contract vehicle 36C24123A0040. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Veterans Affairs (NAICS 325413)
- 36C24126F0009 — Fisher Scientific Company L.L.C. · ends November 23, 2026 · $349K
- 36C24426N0199 — Beckman Coulter, INC · ends November 30, 2026 · $129K
- 36C24426N0200 — Beckman Coulter, INC · ends November 30, 2026 · $115K
- 36C24426N0201 — Beckman Coulter, INC · ends November 30, 2026 · $104K
- 36C24426N0202 — Beckman Coulter, INC · ends November 30, 2026 · $110K
- 36C24526P0090 — Cepheid · ends November 30, 2026 · $215K
- 36C25026N0722 — Sebia, INC. · ends November 30, 2026 · $103K
- 36C25726N0059 — Qiagen, LLC · ends November 30, 2026 · $107K
- 36C25926N0155 — Abbott Molecular INC. · ends November 30, 2026 · $350K
- 36C26024P0112 — Biofire Diagnostics LLC · ends November 30, 2026 · $644K